HIN
Click for more information
0.00% $2.37 heartware international, inc

mrjezza Q4 approval is for HVAD as a bridge to transplant device.

  1. chrisnj
    998 Posts.
    lightbulb Created with Sketch. 12
    clock Created with Sketch.
    27/08/11
    16:44
    Post #: 8881469
    mrjezza Q4 approval is for HVAD as a bridge to transplant device.
    HIN Price at posting: $1.63 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.